Chicago Equity Partners’s Exact Sciences EXAS Stock Holding History

Chicago Equity Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,230	Closed	-$1.22M	–	729
2019 Q4	$1.22M	Hold	13,230	–	–	0.07%	395
2019 Q3	$1.2M	Sell	13,230 -9,945	-43%	-$1.13M	0.06%	447
2019 Q2	$2.74M	Sell	23,175 -4,580	-17%	-$461K	0.12%	243
2019 Q1	$2.4M	Sell	27,755 -31,015	-53%	-$2.64M	0.09%	304
2018 Q4	$3.71M	Sell	58,770 -4,350	-7%	-$299K	0.15%	188
2018 Q3	$4.98M	Buy	63,120 +6,390	+11%	+$417K	0.15%	187
2018 Q2	$3.39M	Buy	56,730 +17,325	+44%	+$932K	0.1%	285
2018 Q1	$1.59M	Buy	39,405 +200	+0.5%	+$9.76K	0.05%	422
2017 Q4	$2.06M	Sell	39,205 -9,860	-20%	-$526K	0.06%	358
2017 Q3	$2.31M	Buy	+49,065	New	+$1.97M	0.07%	340

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chicago Equity Partners's EXAS Position: Q1 2020 in Review

Chicago Equity Partners sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 13,230 shares — an estimated $1.22M sold.

Chicago Equity Partners first reported a position in EXAS in Q3 2017 and held it in 10 quarters. The position peaked at $4.98M in Q3 2018. 475 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

Chicago Equity Partners reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 13,230 Exact Sciences shares in Q1 2020, an estimated $1.22M.
Chicago Equity Partners first reported a position in Exact Sciences in Q3 2017 and held it in 10 quarters.
Chicago Equity Partners's Exact Sciences position peaked at $4.98M in Q3 2018.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.